跳至主要内容
临床试验/NCT01446692
NCT01446692已完成不适用

Therapeutic Strategies for the Management of Patients With Major Depressive Disorder (MDD) and Suboptimal Response to Antidepressant Drugs in Primary Care: the Badalona Database Study

AstraZeneca1 个研究点 分布在 1 个国家目标入组 2,260 人开始时间: 2011年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
2,260
试验地点
1
主要终点
Description of the antidepressant strategies switches

研究概览

简要总结

A retrospective study using a data base of anonymized medical records. The purpose of the study is to examine the different therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care

详细描述

Therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care: the Badalona database study

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • An International Classification of Primary Care (ICPC-2) or DSM-IV-TR diagnosis for major depressive disorder (MDD)
  • At least 8 weeks of antidepressant treatment during the identification period of 01 January 2008 - 31 December 2009
  • 18 months of enrollment with medical and pharmacy records after index episode date

排除标准

  • 未提供

结局指标

主要结局

Description of the antidepressant strategies switches

时间窗: 18 months

Number and type of treatment changes including combination, switch, or augmentation strategies.

次要结局

  • Health care costs(18 months)
  • Hamilton Depression Rating Scale(18 months)
  • Medication possession rate to evaluate adherence(18 months)
  • Health care resource utilization(18 months)
  • Referral to psychiatrist office(18 months)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Badalona Major Depressive Disorder Database Study | 临床试验